跳至主要内容
临床试验/ACTRN12624000755538
ACTRN12624000755538尚未招募Unknown

Positron Emission Tomography with AT-01 to Diagnose and Monitor Amyloidosis: A Prospective Cohort Pilot Study in Adult Patients.

Metro South Health0 个研究点目标入组 30 人开始时间: 2024年6月19日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Diagnosis of amyloidosis with the known following subtype:
  • (a) Systemic AL amyloidosis prior to therapy commencement (n=15)
  • (b) Systemic AL amyloidosis with suboptimal response to therapy or in early biochemical relapse (n=5)
  • (c) ATTRwt amyloidosis (n=5)
  • (d) Other systemic amyloidosis i.e. ALECT2 and Alys amyloidosis (n=5)
  • 2. Age equal to or greater than 18yrs
  • 3. Life expectancy greater than 3 months

排除标准

  • 1.Localised amyloidosis
  • 2.Known iodine or potassium iodide hypersensitivity
  • 3.Patients being treated with heparin and heparin like anticoagulant therapy (due to interaction with AT-01)
  • 4.Patients who are pregnant and/or breastfeeding

研究者

发起方
Metro South Health

相似试验